Literature DB >> 18063079

Functional parathyroid carcinoma: Long-term treatment outcome and risk factor analysis.

Masatoshi Iihara1, Takahiro Okamoto, Rumi Suzuki, Akiko Kawamata, Toshio Nishikawa, Makio Kobayashi, Takao Obara.   

Abstract

BACKGROUND: This study was conducted to evaluate the long-term outcome of surgical treatment in patients with functional parathyroid carcinoma and to clarify factors determining prognosis.
METHODS: A retrospective review of 38 patients with parathyroid carcinoma was performed. The Ki-67 index was evaluated in 29 cases. Disease-free survival and cause-specific survival estimated using the Kaplan-Meier method were analyzed, and the median follow-up period was 119 months.
RESULTS: Fifteen patients developed persistent or recurrent parathyroid carcinoma, and 9 patients died of the disease. Twenty-one of 41 reoperations normalized the serum calcium level for at least 6 months. Univariate and multivariate analyses showed that locoregional tumor extension at initial operation and Ki-67 index >or=5% were significant factors affecting cause-specific survival (P = .0008, P = .05) and disease-free survival (P = .0005, P = .005), respectively. Five of 6 patients whose tumor showed a Ki-67 index >or=10% developed recurrence within 3 years after initial operation, and 4 died of the disease.
CONCLUSIONS: Parathyroid carcinomas with locoregional extension at initial surgery have potential for recurrence. Our data suggest that aggressive surgical resection of recurrent parathyroid carcinoma is beneficial for palliation of hypercalcemia in selected patients. Ki-67 staining may be a valuable prognostic factor for patients with parathyroid carcinoma, especially as tumors with indices greater than 10% are more likely to recur in the early postoperative period.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063079     DOI: 10.1016/j.surg.2007.09.014

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  12 in total

1.  Lymph node involvement and surgical approach in parathyroid cancer.

Authors:  Klaus-Martin Schulte; Nadia Talat; John Miell; Caje Moniz; Prakash Sinha; Salvador Diaz-Cano
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

2.  Parathyroid carcinoma encountered after minimally invasive focused parathyroidectomy may not require further radical surgery.

Authors:  Christine J O'Neill; Conan Chan; James Symons; Diana L Learoyd; Stan B Sidhu; Leigh W Delbridge; Anthony Gill; Mark S Sywak
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

Review 3.  Parathyroid cancer.

Authors:  John M Sharretts; Electron Kebebew; William F Simonds
Journal:  Semin Oncol       Date:  2010-12       Impact factor: 4.929

4.  Mortality factors in recurrent parathyroid cancer: a pooled analysis.

Authors:  Wen-Hsuan Tsai; Yi-Hong Zeng; Chun-Chuan Lee; Ming-Chieh Tsai
Journal:  J Bone Miner Metab       Date:  2022-02-20       Impact factor: 2.626

Review 5.  Parathyroid carcinoma: etiology, diagnosis, and treatment.

Authors:  Takahiro Okamoto; Masatoshi Iihara; Takao Obara; Toshihiko Tsukada
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

6.  Case report on giant parathyroid adenoma with review of literature.

Authors:  Rajesh Sisodiya; Sampath Kumar; Nagraj Palankar; Dinesh B V
Journal:  Indian J Surg       Date:  2011-05-20       Impact factor: 0.656

7.  Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism.

Authors:  Jae Hyun Bae; Hyung Jin Choi; Yenna Lee; Min Kyong Moon; Young Joo Park; Chan Soo Shin; Do Jun Park; Hak Chul Jang; Seong Yeon Kim; Sang Wan Kim
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

8.  Parathyroid carcinoma in a 13-year-old girl with a long-term survival.

Authors:  Yoko Omi; Tomoko Yamamoto; Yoji Nagashima; Koichiro Abe; Kumiko Karasawa; Yukichi Tanaka; Takahiro Okamoto
Journal:  Surg Case Rep       Date:  2020-06-22

9.  Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.

Authors:  Arturs Ozolins; Zenons Narbuts; Andrejs Vanags; Zane Simtniece; Zane Visnevska; Aycan Akca; Denis Wirowski; Janis Gardovskis; Ilze Strumfa; Peter E Goretzki
Journal:  Langenbecks Arch Surg       Date:  2015-12-11       Impact factor: 3.445

10.  Clinical characteristics and treatment outcomes of parathyroid carcinoma: A retrospective review of 234 cases.

Authors:  Peisong Wang; Shuai Xue; Shuo Wang; Zhi Lv; Xianying Meng; Guimin Wang; Wei Meng; Jia Liu; Guang Chen
Journal:  Oncol Lett       Date:  2017-09-27       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.